BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261005T000000
DTEND;TZID=America/New_York:20261008T000000
DTSTAMP:20260826T191012
CREATED:20260709T155448Z
LAST-MODIFIED:20260709T155448Z
UID:100123032-1791158400-1791417600@www.pathologynews.com
SUMMARY:16th Annual World CB & CDx Summit
DESCRIPTION:0000Days00Hrs00Min00SecAccelerating Complex Biomarkers\, Novel & Multimodal Endpoints to Fuel Drug-Diagnostic Innovations from Bench-to-Bedside for Global Precision Medicine Access \nAs regulatory headwinds turn to tailwinds\, precision medicine is shifting into a new gear. \nEvolving FDA approaches to LDTs and 510(k) pathways are removing long-standing friction\, coordinated Rx-Dx launches are gaining pace\, ctDNA and MRD are advancing as clinically meaningful endpoints\, and reimbursement expansion is improving access to high-value genomic testing. At the same time\, innovation in multiplex assays\, multi-omics platforms\, liquid biopsy\, digital pathology\, spatial biology\, and AI-powered diagnostics\, are rapidly reshaping the IVD landscape. \nFueled by $60B+ in diagnostic deal-making and strategic partnerships\, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns as the industry’s esteemed end-to-end precision medicine forum. Convening 850+ senior leaders from biopharma\, diagnostic\, regulatory\, healthcare\, testing labs and multimodal communities\, with expertise spanning the full value chain\, gain the insights\, partnerships and insider know-how to prime your team for continued clinical and commercial success. \nWith the race to bring scalable\, accessible drug-diagnostic programs from bench-to-bedside heating up\, join us in harnessing the speed\, scale\, and growing complexity of innovation happening in next-generation IVD platforms\, multimodal data\, and CDx development. \nRegister Now\n\n\n\n\nDelve into the Brand-New Agenda\n\n\n\n\n\n\n\n\n\n\n\n\nFree* Attendance for Representatives from Biopharma & Academia \nYour Globally Leading Biomarker & Companion Diagnostics Forum \nAccess Numerous Strategic Rx-Dx Co-Development & Partnership Selection Panels \nPartake in Multiple Biomarker Sessions Spanning Oncology\, Hematology & Neurological\, Chronic\, Autoimmune & Rare Diseases\nDiscover Brand-New Case Studies on Digital Pathology\, Multimodal Data & AI-Enabled Precision Medicine \nTake Advantage of Unmatched\, Exclusive Networking & Partnerships Opportunities 
URL:https://www.pathologynews.com/event/16th-annual-world-cb-cdx-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/07/16th-Annual-World-CB-CDx-Summit.jpg
END:VEVENT
END:VCALENDAR